Adam Kretz has experience at the trial and appellate level in a wide variety of complex litigation matters, with a focus on product liability litigation. He has particular experience in dispositive motion practice, including summary judgment and Daubert motions, as well as overseeing discovery and fact development in mass tort and class actions. Mr. Kretz currently represents major pharmaceutical companies in both mass tort product liability actions and government investigations concerning the prescription drug Plavix®. He also maintains an active pro bono practice focused on civil rights issues facing the LGBTQ and immigrant communities.
Mr. Kretz graduated from Colorado College, where he was a champion debater, and Stanford Law School, where he was Editor-in-Chief of the Stanford Law & Policy Review and recipient of the Hilmer Oehlmann, Jr. Prize in legal writing. Prior to attending law school, he was a policy analyst, focusing on state tax issues, at the Colorado Fiscal Policy Institute.
- Bristol-Myers Squibb and Sanofi as counsel in the Plavix product liability litigation and state attorneys general investigations.
- The Oakland Raiders as counsel in an employment and antitrust class action brought by the team's cheerleaders.
- Residential Builder as lead associate and second-chair trial counsel in an ownership dispute over historic property.
- Construction Management Company as trial and appellate counsel in civil fraud and government contract litigation regarding a school construction contract.
- JD, Stanford Law School, 2013
- BA, Colorado College, 2008, magna cum laude, Phi Beta Kappa
- US District Court, Northern District of California, The Honorable Beth Labson Freeman